AI assistant
MICRO-X LIMITED — Capital/Financing Update 2018
Dec 23, 2018
65388_rns_2018-12-23_80da98ed-0d60-4610-9a80-89af2d151e8b.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [127 x 36] intentionally omitted <==
Micro-X Limited, 1284 South Road, Tonsley, Clovelly Park, South Australia, 5042
ABN: 21 153 273 735
Monday 24[th] December 2018
ASX Announcement – MICRO-X LIMITED (ASX: MX1)
COMPLETION OF CAPITAL RAISE
Micro-X Limited (ASX: MX1) is pleased to advise the market of the successful private placement of 7.4M Ordinary Shares to raise A$2,000,000 at an issue price of $0.27 per new Share (the ‘Issue’). The capital raise was supported by existing institutional and HNW investors. Under the terms of the Issue investors will also receive call options on a 1 for 2 basis – 3.7M options in total. The options will be unlisted and have an exercise price of $0.40 and an expiry date of 31 December 2020.
The funds raised will provide support for general working capital to support production ramp-up of the Carestream DRX Revolution Nano and were issued under existing placement capacity under listing rule 7.1.
For further information please contact:
Mr Peter Rowland, Managing Director, Micro-X Limited
Telephone: +61 418 844 981 [email protected] www.micro-x.com
About Micro-X : Micro-X Limited (“ MX1 ”) is an Australian Securities Exchange listed company developing and commercialising a range of highly innovative products based on proprietary carbon nanotube emitter technologies exclusively licensed and sourced from XinRay Systems Inc., a US based technology developer. These technologies enable the miniaturisation of a number of X-ray applications relevant to large global markets.